CAMBRIDGE, England--(BUSINESS WIRE)--The Mundipharma global network of independent associated companies has today added development capabilities to its biosimilars platform with the purchase of biosimilars development company Cinfa Biotech.
Novartis' generics arm Sandoz is launching its long-acting buprenophine patch Reletrans in the UK following victory in a patent battle with Napp Pharmaceuticals.
Cost regulators for the National Health Service in England and Wales have expanded treatment options for patients with ankylosing spondylitis